PANCREATIC CANCER, ADULT

Clinical trials for PANCREATIC CANCER, ADULT explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC CANCER, ADULT trials appear

Sign up with your email to follow new studies for PANCREATIC CANCER, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 3 Not yet finished but already full! 1

New hope for tough pancreatic cancer cases in early drug trial

Disease control Ongoing

This is a first-in-human study to find a safe dose of a new drug, GP-2250, when given with the chemotherapy gemcitabine. It is for adults with advanced pancreatic cancer that has continued to grow despite prior treatment. The main goal is to check for side effects and see how the…

Matched conditions: PANCREATIC CANCER, ADULT

Phase: PHASE1 • Sponsor: Geistlich Pharma AG • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PANCREATIC CANCER, ADULT

Get alerted when new PANCREATIC CANCER, ADULT trials appear

New hope for tough pancreatic cancer cases in early drug trial